deltatrials
Terminated INTERVENTIONAL NCT04855123

Evaluation of the Degradation of Renal Function Post Nephrectomy According to Retinal Vascularisation Parameters (NEPHRIN)

Evaluation of the Degradation of Renal Function Post Nephrectomy According to Retinal Vascularisation Parameters "NEPHRIN"

Sponsor: Centre Hospitalier Universitaire Dijon

Updated 8 times since 2021 Last updated: Apr 22, 2026 Started: Mar 18, 2021 Primary completion: Mar 5, 2026 Completion: Mar 5, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Changes in clinical practice have led to a decrease in the number of nephrectomies performed in the target population, which has prevented us from recruiting the necessary number of participants within a reasonable timeframe.

A observational or N/A phase clinical study on Nephrostomy and Retinal Vascularisation, this trial is terminated or withdrawn. The trial is conducted by Centre Hospitalier Universitaire Dijon and has accumulated 8 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~May 2021 – ~Nov 2021 · 6 months · monthly snapshotRecruiting~Nov 2021 – ~May 2023 · 18 months · monthly snapshotRecruiting~May 2023 – ~Jun 2023 · 31 days · monthly snapshotRecruiting~Jun 2023 – ~Jun 2024 · 12 months · monthly snapshotRecruiting~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Apr 2026 · 20 months · monthly snapshotRecruitingApr 28, 2026 – present · 2 months · daily APITerminated

Change History

8 versions recorded
  1. Apr 28, 2026 — Present [daily]

    Terminated

    Status: RecruitingTerminated · Phase: NANone

  2. Sep 2024 — Apr 2026 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Jun 2024 — Jul 2024 [monthly]

    Recruiting NA

  5. Jun 2023 — Jun 2024 [monthly]

    Recruiting NA

Show 3 earlier versions
  1. May 2023 — Jun 2023 [monthly]

    Recruiting NA

  2. Nov 2021 — May 2023 [monthly]

    Recruiting NA

  3. May 2021 — Nov 2021 [monthly]

    Recruiting NA

    First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

Chronic kidney failure in the single remaining kidney is one of the dreaded complications of nephrectomy in patients operated on for cancer-related reasons (1). Indeed, chronic kidney disease (CKD) is associated with major cardiovascular morbidity and mortality (2). To date, there are few non-invasive methods available to predict the onset and progression of CKD in patients for whom nephrectomy is indicated. Preoperative creatinine and glomerular filtration rate are poor predictors of the subsequent risk of single kidney failure (1). Early predictive markers could help anticipate the management of CKD in patients for whom progression to end-stage renal disease is predictable. Furthermore, such markers could be used as a decision-making aid to specify the type of nephrectomy to be preferred (total versus partial nephrectomy). The state of microcirculation, particularly retinal, is correlated with the progression of certain conditions such as diabetic nephropathy (3-5). A new technique for evaluating retinal microcirculation called OCT-A (an imaging technique in ophthalmology allowing a precise non-invasive study of the retinal microvascular network) has recently been used by our team to highlight an association between retinal vascularisation and the level of cardiovascular risk in a population of coronary patients without diabetes (6). We hypothesize that the observation of retinal vascular abnormalities could reflect changes in kidney structure that could underlie chronic renal failure. The aim of this work is thus to evaluate whether the presence of abnormalities in the retinal microvascularisation is 1) predictive of the deterioration in renal function one year after nephrectomy for cancer-related reasons and 2) correlated with renal histological abnormalities.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire Dijon
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations